A Wee1-like protein kinase 2 that is encoded in the genome of human. [PRO:DNx, UniProtKB:P0C1S8]
EC 2.7.10.2;
Wee1-like protein kinase 1B;
Wee1B kinase
Timeframe | Studies on this Protein(%) | All Drugs % |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (33.33) | 29.6817 |
2010's | 2 (66.67) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Drug | Taxonomy | Measurement | Average (mM) | Bioassay(s) | Publication(s) |
---|---|---|---|---|---|
imatinib | Homo sapiens (human) | Kd | 10.0000 | 1 | 1 |
staurosporine | Homo sapiens (human) | Kd | 10.0000 | 1 | 1 |
gefitinib | Homo sapiens (human) | Kd | 10.0000 | 1 | 1 |
lestaurtinib | Homo sapiens (human) | Kd | 8.9500 | 2 | 2 |
vatalanib | Homo sapiens (human) | Kd | 10.0000 | 1 | 1 |
ruboxistaurin | Homo sapiens (human) | Kd | 10.0000 | 1 | 1 |
canertinib | Homo sapiens (human) | Kd | 10.0000 | 1 | 1 |
birb 796 | Homo sapiens (human) | Kd | 10.0000 | 1 | 1 |
sb 203580 | Homo sapiens (human) | Kd | 10.0000 | 1 | 1 |
enzastaurin | Homo sapiens (human) | Kd | 10.0000 | 1 | 1 |
erlotinib | Homo sapiens (human) | Kd | 10.0000 | 1 | 1 |
lapatinib | Homo sapiens (human) | Kd | 10.0000 | 1 | 1 |
sorafenib | Homo sapiens (human) | Kd | 10.0000 | 2 | 2 |
pd 173955 | Homo sapiens (human) | Kd | 0.0570 | 1 | 1 |
s 1033 | Homo sapiens (human) | Kd | 10.0000 | 1 | 1 |
bms 387032 | Homo sapiens (human) | Kd | 10.0000 | 1 | 1 |
tandutinib | Homo sapiens (human) | Kd | 10.0000 | 2 | 2 |
vx-745 | Homo sapiens (human) | Kd | 10.0000 | 1 | 1 |
dasatinib | Homo sapiens (human) | Kd | 0.3405 | 2 | 2 |
zd 6474 | Homo sapiens (human) | Kd | 10.0000 | 1 | 1 |
alvocidib | Homo sapiens (human) | Kd | 10.0000 | 1 | 1 |
pd 166285 | Homo sapiens (human) | Kd | 0.0050 | 1 | 1 |
bosutinib | Homo sapiens (human) | Kd | 0.1000 | 2 | 2 |
su 11248 | Homo sapiens (human) | Kd | 10.0000 | 2 | 2 |
vx680 | Homo sapiens (human) | Kd | 4.2000 | 1 | 1 |
ekb 569 | Homo sapiens (human) | Kd | 0.4980 | 1 | 1 |
axitinib | Homo sapiens (human) | Kd | 10.0000 | 1 | 1 |
pd 184352 | Homo sapiens (human) | Kd | 10.0000 | 1 | 1 |
bms345541 | Homo sapiens (human) | Kd | 10.0000 | 1 | 1 |
midostaurin | Homo sapiens (human) | Kd | 10.0000 | 2 | 2 |
ki 20227 | Homo sapiens (human) | Kd | 10.0000 | 1 | 1 |
pi103 | Homo sapiens (human) | Kd | 10.0000 | 1 | 1 |
hki 272 | Homo sapiens (human) | Kd | 1.3000 | 1 | 1 |
tofacitinib | Homo sapiens (human) | Kd | 10.0000 | 1 | 1 |
n-(6-chloro-7-methoxy-9h-beta-carbolin-8-yl)-2-methylnicotinamide | Homo sapiens (human) | Kd | 10.0000 | 1 | 1 |
cediranib | Homo sapiens (human) | Kd | 10.0000 | 1 | 1 |
masitinib | Homo sapiens (human) | Kd | 10.0000 | 1 | 1 |
pazopanib | Homo sapiens (human) | Kd | 10.0000 | 1 | 1 |
azd 6244 | Homo sapiens (human) | Kd | 10.0000 | 1 | 1 |
su 14813 | Homo sapiens (human) | Kd | 10.0000 | 1 | 1 |
bibw 2992 | Homo sapiens (human) | Kd | 10.0000 | 1 | 1 |
tg100-115 | Homo sapiens (human) | Kd | 10.0000 | 1 | 1 |
pha 665752 | Homo sapiens (human) | Kd | 10.0000 | 1 | 1 |
6-[[5-fluoro-2-(3,4,5-trimethoxyanilino)-4-pyrimidinyl]amino]-2,2-dimethyl-4H-pyrido[3,2-b][1,4]oxazin-3-one | Homo sapiens (human) | Kd | 9.4000 | 1 | 1 |
brivanib | Homo sapiens (human) | Kd | 10.0000 | 1 | 1 |
at 7519 | Homo sapiens (human) | Kd | 10.0000 | 1 | 1 |
bi 2536 | Homo sapiens (human) | Kd | 10.0000 | 1 | 1 |
nvp-ast487 | Homo sapiens (human) | Kd | 10.0000 | 1 | 1 |
kw 2449 | Homo sapiens (human) | Kd | 4.7000 | 1 | 1 |
abt 869 | Homo sapiens (human) | Kd | 10.0000 | 1 | 1 |
gw 2580 | Homo sapiens (human) | Kd | 10.0000 | 1 | 1 |
crizotinib | Homo sapiens (human) | Kd | 10.0000 | 1 | 1 |
chir-265 | Homo sapiens (human) | Kd | 10.0000 | 1 | 1 |
motesanib | Homo sapiens (human) | Kd | 10.0000 | 1 | 1 |
mln8054 | Homo sapiens (human) | Kd | 10.0000 | 1 | 1 |
GDC-0879 | Homo sapiens (human) | Kd | 10.0000 | 1 | 1 |
gsk 461364 | Homo sapiens (human) | Kd | 10.0000 | 1 | 1 |
azd 1152-hqpa | Homo sapiens (human) | Kd | 10.0000 | 1 | 1 |
nvp-tae684 | Homo sapiens (human) | Kd | 10.0000 | 1 | 1 |
pha 848125 | Homo sapiens (human) | Kd | 0.0266 | 1 | 1 |
fedratinib | Homo sapiens (human) | Kd | 6.0000 | 1 | 1 |
gsk690693 | Homo sapiens (human) | Kd | 10.0000 | 1 | 1 |
gdc 0941 | Homo sapiens (human) | Kd | 10.0000 | 1 | 1 |
plx 4720 | Homo sapiens (human) | Kd | 10.0000 | 1 | 1 |
sgx 523 | Homo sapiens (human) | Kd | 10.0000 | 1 | 1 |
mk-1775 | Homo sapiens (human) | Kd | 0.0154 | 2 | 2 |
quizartinib | Homo sapiens (human) | Kd | 10.0000 | 2 | 2 |
incb-018424 | Homo sapiens (human) | Kd | 10.0000 | 1 | 1 |
gsk 1838705a | Homo sapiens (human) | Kd | 10.0000 | 1 | 1 |
gsk 1363089 | Homo sapiens (human) | Kd | 10.0000 | 1 | 1 |
chir 258 | Homo sapiens (human) | Kd | 10.0000 | 1 | 1 |
nintedanib | Homo sapiens (human) | Kd | 10.0000 | 1 | 1 |
pp242 | Homo sapiens (human) | Kd | 10.0000 | 1 | 1 |
This protein enables 4 target(s):
Target | Category | Definition |
---|---|---|
magnesium ion binding | molecular function | Binding to a magnesium (Mg) ion. [GOC:ai] |
non-membrane spanning protein tyrosine kinase activity | molecular function | Catalysis of the reaction: ATP + protein L-tyrosine = ADP + protein L-tyrosine phosphate by a non-membrane spanning protein. [EC:2.7.10.2] |
ATP binding | molecular function | Binding to ATP, adenosine 5'-triphosphate, a universally important coenzyme and enzyme regulator. [ISBN:0198506732] |
protein tyrosine kinase activity | molecular function | Catalysis of the reaction: ATP + a protein tyrosine = ADP + protein tyrosine phosphate. [RHEA:10596] |
This protein is located in 3 target(s):
Target | Category | Definition |
---|---|---|
nucleoplasm | cellular component | That part of the nuclear content other than the chromosomes or the nucleolus. [GOC:ma, ISBN:0124325653] |
cytosol | cellular component | The part of the cytoplasm that does not contain organelles but which does contain other particulate matter, such as protein complexes. [GOC:hjd, GOC:jl] |
plasma membrane | cellular component | The membrane surrounding a cell that separates the cell from its external environment. It consists of a phospholipid bilayer and associated proteins. [ISBN:0716731363] |
This protein is active in 2 target(s):
Target | Category | Definition |
---|---|---|
cytoplasm | cellular component | The contents of a cell excluding the plasma membrane and nucleus, but including other subcellular structures. [ISBN:0198547684] |
nucleus | cellular component | A membrane-bounded organelle of eukaryotic cells in which chromosomes are housed and replicated. In most cells, the nucleus contains all of the cell's chromosomes except the organellar chromosomes, and is the site of RNA synthesis and processing. In some species, or in specialized cell types, RNA metabolism or DNA replication may be absent. [GOC:go_curators] |
This protein is involved in 8 target(s):
Target | Category | Definition |
---|---|---|
mitotic cell cycle | biological process | Progression through the phases of the mitotic cell cycle, the most common eukaryotic cell cycle, which canonically comprises four successive phases called G1, S, G2, and M and includes replication of the genome and the subsequent segregation of chromosomes into daughter cells. In some variant cell cycles nuclear replication or nuclear division may not be followed by cell division, or G1 and G2 phases may be absent. [GOC:mah, ISBN:0815316194, Reactome:69278] |
female meiotic nuclear division | biological process | A cell cycle process by which the cell nucleus divides as part of a meiotic cell cycle in the female germline. [GOC:dph, GOC:ems, GOC:mah, GOC:vw] |
female pronucleus assembly | biological process | Assembly of the haploid nucleus of the unfertilized egg. [GOC:bf, ISBN:0582227089] |
positive regulation of phosphorylation | biological process | Any process that activates or increases the frequency, rate or extent of addition of phosphate groups to a molecule. [GOC:jl] |
regulation of meiosis I | biological process | Any process that modulates the rate, frequency, or extent of meiosis I, a cell cycle process comprising the steps by which a cell progresses through the first phase of meiosis, in which cells divide and homologous chromosomes are paired and segregated from each other, producing two daughter cells. [GOC:dph, GOC:tb] |
regulation of fertilization | biological process | Any process that modulates the rate, frequency or extent of fertilization. Fertilization is the union of gametes of opposite sexes during the process of sexual reproduction to form a zygote. It involves the fusion of the gametic nuclei (karyogamy) and cytoplasm (plasmogamy). [GOC:DHL, PMID:20478994] |
negative regulation of oocyte maturation | biological process | Any process that stops, prevents or reduces the frequency, rate or extent of oocyte maturation. [GOC:kmv, GOC:TermGenie] |
protein phosphorylation | biological process | The process of introducing a phosphate group on to a protein. [GOC:hb] |